Algo version: 0.98b
MBRX is listed at the NASDAQ Exchange
MBRX [MBRX]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is MBRX stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Moleculin Biotech Inc 10 years ago, but if you had invested on Thursday 2nd of June 2016 when the price was $720.00, you would have made a loss of $-717.58 per share or -99.66%

No, the average daily trading liquidity for Moleculin Biotech Inc is $95 594 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

Moleculin Biotech Inc has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Moleculin Biotech Inc to be medium [0.7 out of 1]